Israel's Innovation Authority has approved a $1.8m grant for LightSolver's all-optical Laser Processing Unit, targeting PDE hardware and HPC integration.

CollPlant stock news: LightSolver’s 2028 goal, $3.7M financing, rhCollagen, cash burn and milestone warrants shaping CLGN’s transformation.

CollPlant stock news: LightSolver’s 2028 goal, $3.7M financing, rhCollagen, cash burn and milestone warrants shaping CLGN’s transformation.

CollPlant Biotechnologies has announced the successful completion of a $3.7 million private placement led by existing investors, aimed at enhancing its Laser-Based Computing technologies.

CollPlant Biotechnologies' subsidiary LightSolver has filed a provisional patent to enhance its laser-based computing platform, opening new possibilities for scientific simulations.

CollPlant Biotechnologies announces its Q2 2026 financial results and outlines strategic advancements following the acquisition of LightSolver.

LightSolver and HLRS's recent research reveals that photonic computing can significantly enhance the speed of high-performance computing tasks, showing astonishing time-to-solution accelerations.

CollPlant Biotechnologies has successfully regained compliance with Nasdaq listing criteria, bolstered by its recent acquisition of LightSolver, enhancing its position in biotechnology and photonics.

CollPlant Biotechnologies invites investors to its LightSolver webinar on September 17, 2026, unveiling innovations in photonic computing.

Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.

CollPlant Biotechnologies has appointed Dr. Ruti Ben Shlomi, CEO of LightSolver, to its Board of Directors after acquiring the company, enhancing photonic computing initiatives.

CollPlant Biotechnologies (CLGN) appointed Dr. Ruti Ben Shlomi, CEO and Co‑Founder of LightSolver, to its Board of Directors, effective immediately following the completion of CollPlant's acquisition of LightSolver announced on September 3, 2026.LightSolver develops a proprietary Laser Processing Unit (LPU), an all‑optical, energy‑efficient photonic computing platform designed to accelerate computationally intensive workloads in scientific simulation, engineering, optimization and Physical AI. CollPlant states that Dr. Ben Shlomi's deep expertise in photonic computing and entrepreneurship will support the commercialization of this newly acquired technology.With the LightSolver acquisition, CollPlant expands from regenerative medicine into advanced high‑performance computing, aiming to address demanding workloads in aerospace, defense and Physical AI while continuing its collagen-based 3D bioprinting, tissue repair and medical aesthetics activities.

LightSolver Founder and CEO brings deep scientific and entrepreneurial expertise to CollPlant's Board as the Company advances the commercialization of its newly acquired photonic computing technology REHOVOT, Israel, Sept. 4, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq:...

The transaction included a $5 million investment in LightSolver, upfront shares and pre-funded warrants, with more warrants tied to technology and commercial objectives.

CollPlant has successfully completed the acquisition of LightSolver, marking its entry into photonic computing and high-performance computing sectors.

Technological Edge - LightSolver advances the development of the world's first Laser Processing Unit (LPU) – an energy-efficient, pure photonic computing platform Accelerated Growth Path - The transaction positions LightSolver to accelerate its path towards commercialization and expand...